Announcements

New Impact Factor for Annals of Translational Medicine: 3.297

Published: 2020-06-30

We are pleased to announce that the Annals of Translational Medicine (ATM) has attained its latest impact factor update for the 2019 citation year: 3.297.

The Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed, open access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is indexed in PubMed in Sept 2014 and in SCIE in 2018 (2018 Impact Factor: 3.689). Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.

Aiming for the continued development of article quality alongside the growth of the numbers of submissions, we have recently emphasized improving the publication quality and processing transparency. Some significant arrangements were made in ATM in the past few months:

1. Integration with Publons. As of April 2020, our publisher AME Publishing Company has entered into an official partnership with Publons. Thus, ATM’s peer review system is now integrated seamlessly into the Publons platform (https://publons.com/publisher/6041/ame-publishing-company). The partnership allows for the contributions of our expert peer-reviewers to be recognized anytime. For more information, see: http://atm.amegroups.com/announcement/view/3755.

2. Reporting guidelines for original research. For a higher standard of publishing and research quality, we have introduced a series of reporting guidelines for different research types. Each original research submission to ATM is now required to follow the EQUATOR research reporting guidelines and should include a checklist. If the article is accepted, the related reporting checklist will be published online with the article. For more details, please check the updated guidelines for authors: http://atm.amegroups.com/pages/view/guidelines-for-authors.

3. Transparent peer review process. To commit to openness and accountability, and to increase the level of transparency throughout our peer review process, our Editorial Office has decided to implement a transparent peer review process as an option for all manuscripts submitted to ATM from March 19, 2020. Click here for further information: http://atm.amegroups.com/announcement/view/3746.

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in translational medicine to bring more exciting content to readers in the coming future.


Editorial Office
Annals of Translational Medicine
June 30, 2020